AI CAPITAL INTELLIGENCE
高维医药 funding history
1 recorded financing disclosures for 高维医药. Dates, rounds, currencies and original sources follow the individual records. This is not a complete company funding history.
Latest recorded funding, at a glance
The latest disclosure recorded for 高维医药 is dated 2026-10-14: Pre-A, CNY 200,000,000–900,000,000 (reported range). Named investors: 华泰金斯瑞基金, 东方嘉富, 国方创投, 瑞力投资, 楚昌基金, 兴华鼎立, 西湖创新, 广发信德. This is the latest record in our coverage, not a claim about all company financing.
View funding details · Original source 1 · Original source 2 · Original source 3 · Original source 4 · Original source 5
Funding disclosures
| Disclosure date | Round | Disclosed amount | Named investors | Evidence |
|---|---|---|---|---|
| Pre-A | CNY 200,000,000–900,000,000 (reported range) | 华泰金斯瑞基金, 东方嘉富, 国方创投, 瑞力投资, 楚昌基金, 兴华鼎立, 西湖创新, 广发信德 | Record · Source 1 · Source 2 · Source 3 · Source 4 · Source 5 |
Recorded financing disclosures
- 高维医药2026-10-14 · Pre-A · CNY 200,000,000–900,000,000 (reported range)
Disclosed investors across recorded rounds
Publicly disclosed founding team
- 李旭 · 创始人、董事长